AMICUS THERAPEUTICS, INC. — Director's Dealing 2010

Jun 15, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2010-06-15

Reporting Person: BARRETT M JAMES (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-15	Director Stock Option (Right to Buy)	$2.81	A	10000	Acquired	2020-06-15	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3659157	Indirect

Footnotes

F1: The stock option vests and becomes exercisable in full on the date of the issuer's annual meeting of stockholders that occurs in 2011, provided that if the Reporting Person ceases to be a director of the issuer, the stock option shall cease to be exercisable in any respect not later than ninety (90) days following that event.

F2: The Reporting Person is an individual manager of NEA 11 GP, LLC ("NEA GP"), the sole general partner of NEA Partners 11, Limited Partnership ("NEA Partners 11"). NEA Partners 11 is the sole general partner of New Enterprise Associates 11, Limited Partnership ("NEA 11"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 11 securities in which the Reporting Person has no actual pecuniary interest therein.